FLH Partner Brian J. Malkin will attend the Generic Pharmaceutical Association’s (“GPhA”)’s Annual Conference in Orlando, Florida, from February 22-24. More than 500 attendees will join Mr. Malkin to hear from industry experts and other opinion leaders regarding insight into critical economic, regulatory, and legislative issues, particularly FDA’s new proposed generic user fees, impacting the health care and generic pharmaceutical sector. Each year, GPhA’s Annual Conference features presentations by leading industry CEOs, economists and financial analysts, FDA regulators, and state and federal officials. This year’s conference features a keynote address by Margaret A. Hamburg, M.D., FDA Commissioner. More information about the conference may be found here.